Market LIVE
Published markets; coverage varies by country
Product profile · United States

YORVIPATH

 ·  Patent Litigation & Settlement History ↓

IngredientPALOPEGTERIPARATIDE
Application typeNDA
Application216490
Product003
Dosage formSOLUTION
RouteSUBCUTANEOUS
StrengthEQ 0.42MG TERIPARATIDE/1.4ML (EQ 0.3MG TERIPARATIDE/ML)
Approval date2024-08-09
Marketing statusPrescription
Status event—
ApplicantASCENDIS PHARMA BONE
Product source

Current GenericRadar decision

Year2037
SelectionDEEP_REVIEW
ReviewFINAL
Anchor typePATENT
Anchor date2037-09-28
Patent anchor2037-09-28
Exclusivity anchor2031-08-09
Protection date2042-11-12
First Final ANDA—
Status event—

POST_ANCHOR_RIGHTS_EXIST; US:NDA:216490:003; exact Final ANDA not verified; not proof of generic absence

Patent estate

PatentEffective dateOfficial listingTRUE_DSDS gradeClaim classification / basisPTEPEDFamily
89068472031-04-30DS/DP/U U-3982YNTRUE_DS
English description not available.
———
89068472031-04-30ORANGE_BOOK U-3982YNTRUE_DS
English description not available.
———
115902072037-09-28U U-3982NNU
English description not available.
———
115902072037-09-28ORANGE_BOOK U-3982NNU
English description not available.
———
117595042037-09-28DP —NNDP
English description not available.
———
117595042037-09-28ORANGE_BOOK —NNDP
English description not available.
———
118576032037-09-28U U-3982NNU
English description not available.
———
118576032037-09-28ORANGE_BOOK U-3982NNU
English description not available.
———
118903262037-09-28DS/DP —YNTRUE_DS
English description not available.
———
118903262037-09-28ORANGE_BOOK —YNTRUE_DS
English description not available.
———
119186282037-09-28DS/DP —YNTRUE_DS
English description not available.
———
119186282037-09-28ORANGE_BOOK —YNTRUE_DS
English description not available.
———
122959892037-09-28U U-3982NNU
English description not available.
———
122959892037-09-28ORANGE_BOOK U-3982NNU
English description not available.
———
124537782037-09-28U U-3982NNU
English description not available.
———
124537782037-09-28ORANGE_BOOK U-3982NNU
English description not available.
———
124031822042-11-12DP/U U-3982NNDP
English description not available.
———
124031822042-11-12ORANGE_BOOK U-3982NNDP
English description not available.
———

Regulatory exclusivity

CodeStart dateEnd dateScopeEntire productAll indicationsFull coverage dateCombinationSource
NP2024-08-092027-08-09English description not available.NN—
ODE-492
Full coverage date: —
Source
NCE2024-08-092029-08-09English description not available.YY2029-08-09—Source
NCE2024-08-092029-08-09English description not available.YY2029-08-09
ODE-492
Full coverage date: 2029-08-09
Source
ODE-4922024-08-092031-08-09English description not available.YY2031-08-09—Source
ODE-4922024-08-092031-08-09English description not available.YY2031-08-09
ODE-492
Full coverage date: 2031-08-09
Source

2026-10-10 · CURRENT_SOURCE_RECORDS_FOUND · Historical coverage: NOT_COMPLETE

Generic approval evidence

Application / productEventFinal dateTentative dateApplicantAuthorized genericExact mappingSource
No generic approval facts are linked to this product.

Market Entry Information

API filings, authorized generics and linked regulatory milestones.

API Master Files & Certifications 0 records

Ingredient-level registrations from linked public manufacturer portfolios. A filing does not establish supply to this finished product. DMFs are not FDA approvals.

APIHolder / manufacturerHolder countryFiling typeNumberStatusFiled dateAvailable for referenceSourceLast verified
No master-file or certification records are linked through public manufacturer portfolios.

Authorized Generics 0 records

Authorized generics are shown separately from independent ANDA approvals.

Application / productApplicantEvent / status First marketed Product mappingSourceLast verified
No authorized-generic records are linked to this product.

Tentative ANDA Approvals 0 records

Tentative approval is not final approval. Historical tentative approvals remain visible after a linked final approval.

Application / productApplicantEvent / status Tentative date Follow-up final approvalProduct mappingSourceLast verified
No tentative-approval records are linked to this product.

Paragraph IV Challenges 0 records

Paragraph IV challenges below are sourced from legal records separately from FDA approvals. An ANDA filing, lawsuit or settlement does not establish final approval or commercial launch.

Application / productApplicantEvent / status Certification event date Product mappingSourceLast verified
No structured Paragraph IV certification events are linked in the available approval evidence.

Final ANDA Approvals 0 records

Approval dates do not establish commercial launch. Product mapping is shown for each linked record.

Application / productApplicantEvent / status Final approval date Product mappingSourceLast verified
No final-approval records are linked to this product.
Decision evidence (13)
TypeDateRoleBasisSource
PATENT2031-04-30HISTORICAL_CONTEXTEnglish description not available.Source
PATENT2037-09-28HISTORICAL_CONTEXTEnglish description not available.Source
PATENT2037-09-28HISTORICAL_CONTEXTEnglish description not available.Source
PATENT2037-09-28HISTORICAL_CONTEXTEnglish description not available.Source
PATENT2037-09-28CANONICAL_ANCHOREnglish description not available.Source
PATENT2037-09-28CANONICAL_ANCHOREnglish description not available.Source
PATENT2037-09-28HISTORICAL_CONTEXTEnglish description not available.Source
PATENT2037-09-28HISTORICAL_CONTEXTEnglish description not available.Source
PATENT2042-11-12FTO_TAILEnglish description not available.Source
REGULATORY_EXCLUSIVITY—REGULATORY_SCOPE_CONTEXTEnglish description not available.Source
REGULATORY_EXCLUSIVITY—HISTORICAL_CONTEXTEnglish description not available.Source
REGULATORY_EXCLUSIVITY—REGULATORY_SCOPE_CONTEXTEnglish description not available.Source
REGULATORY_STATUS2037-09-28CANONICAL_DECISIONPOST_ANCHOR_RIGHTS_EXIST; US:NDA:216490:003; exact Final ANDA not verified; not proof of generic absenceSource
Independent legal-event information

Litigation & Settlement History

Settlement launch rights generally apply only to the named parties and product scope. These records do not change GenericRadar patent/exclusivity anchors or current decisions.

No litigation or settlement record currently linked to this product.